Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE ADTM study - Pollack, Charles V.; Steiner, Thorsten (Journal of medical economics, 2017)
Accepted author version posted online: 16 Dec 2016